Leading PCD Pharma Franchise for Combination Ear Drops Tap into the specialized and consistent ENT market with a high-demand formulation. Salvus Pharma, a premier WHO-GMP and ISO certified pharmaceutical company, is offering an exceptional PCD Pharma franchise opportunity for our Gentamicin, Clotrimazole, Lignocaine & Beclomethasone Ear Drops. This powerful combination, branded as Clobinta, provides a multi-action solution for various ear infections, making it a go-to product for ENT specialists and general practitioners. Why Franchise with Us for Multi-Action Ear Drops? A successful PCD franchise starts with a product that doctors trust. Here’s why Clobinta is a cornerstone for a profitable ENT portfolio: Clinically Superior Combination: Our ear drops combine antibacterial, antifungal, anti-inflammatory, and anesthetic properties, offering a comprehensive treatment in a single product, which is highly preferred by clinicians. Guaranteed Quality Assurance: Manufactured in a state-of-the-art facility, Clobinta Ear Drops are sterile, stable, and formulated for maximum efficacy and patient comfort, adhering to the highest quality standards. Monopoly-Based Franchise Rights: We empower our partners with exclusive monopoly rights for their designated territories, enabling you to become the primary supplier of this essential ENT product without internal competition. Dedicated Marketing & Promotional Support: We provide our franchise partners with compelling marketing materials, including product monographs, visual aids, and scientific data that clearly explain the benefits of each active ingredient to healthcare professionals. Robust Supply Chain: Never miss an opportunity. Our efficient logistics ensure that you always have a reliable stock of Clobinta Ear Drops to meet market demand promptly.